Key Highlights

  • MyCelx Technologies Corp. (LSE:MYX) fell 7.20% on 5 October 2026 after a strong run in 2026.
  • First-half 2026 Revenue rose 26%, supported by key produced water contracts.
  • The company says its contract pipeline has tripled following approval by a new oil major.
  • All resolutions were passed at the adjourned annual meeting on 1 October 2026 after the original 17 September meeting failed to reach quorum.
  • MyCelx returned to profit in 2025, materially outperforming market expectations.

MyCelx Stock Falls 7.20% on Profit Taking

MyCelx Technologies Corp. (LSE:MYX), the Georgia, US-based provider of proprietary water treatment technology, saw its shares fall 7.20% on Monday 5 October 2026. The decline came without a negative company announcement and appears to reflect profit taking after a strong period for the stock, which more than doubled during 2026 as the Business returned to profit and won new contracts.

MyCelx has a relatively small free float and modest daily trading volumes, so moves of several percent can occur on limited selling. After good news has been priced in, traders often lock in gains, particularly once a corporate event such as an annual meeting has passed.

Why MyCelx Is in Focus: Growth Inflection and Pipeline Expansion

Investors have been watching LSE:MYX because the company appears to be reaching an inflection point. Its first-half 2026 results, released in September, showed a 26% rise in revenue, supported by key produced water contracts. Produced water, the water that comes up with oil and gas during extraction, is a large and growing market, particularly in the Middle East and the United States, where regulators and operators are focused on treatment and reuse.

MyCelx also said its contract pipeline had tripled following approval by a new oil major, a significant development because major oil companies typically require lengthy qualification processes before adopting new technologies. Approval can open the door to multiple sites and repeat orders.

Return to Profit and Commercial Wins

In its final results for 2025, published in May 2026, MyCelx said it had achieved profitability, materially outperforming market expectations even though revenue came in slightly below forecasts. The company highlighted the Middle East as a focus market. In May 2026, it announced a new Gulf of Mexico Lease award with a super major, and it has been expanding its PFAS remediation offering, targeting the growing market for removing so-called forever chemicals from water.

Annual Meeting Adjournment Resolved

The company's annual meeting, convened on 17 September 2026 in London, was opened but adjourned because a quorum was not present. Under its bylaws, shareholders holding more than 50% of the issued Share Capital must be present in person or by proxy. MyCelx had received votes representing about 46.5% of its share capital, all in favour. The adjourned meeting was held on 1 October 2026 in Norcross, Georgia, and all resolutions, including on directors, the auditor and remuneration, were passed. With that hurdle cleared, some traders may have chosen to take profits.

Key Reasons Behind the 7.20% Fall in LSE:MYX

  • Profit taking: the shares had risen strongly through 2026 on profitability and contract wins.
  • Event completion: with the adjourned annual meeting concluded, short-term catalysts have passed.
  • Thin liquidity: modest daily volumes mean limited selling can move the price materially.
  • Execution expectations: investors now want the tripled pipeline to convert into signed contracts and revenue.
  • Oil and gas exposure: the business remains linked to Upstream activity levels and energy sector spending.

Valuation and Analyst Views

Analysts covering MyCelx have set a consensus target price of around 86p, well above recent trading levels in the mid-50p to mid-60p range. Earlier forecasts had pointed to the company moving into sustained profitability from 2026. If the pipeline converts as hoped, upgrades to forecasts could follow.

What Investors Will Watch Next

The key catalysts for LSE:MYX include new contract announcements from the expanded pipeline, particularly with the newly approved oil major, further produced water awards in the Middle East and the US, PFAS project wins and trading updates confirming continued profitability. Monday's 7.20% decline looks more like a pause after a strong run than a change in the underlying story.